BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7623565)

  • 1. Mycophenolate mofetil for transplantation: new drug, old problems?
    Gray DW
    Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive activity of mycophenolate mofetil.
    Eugui EM; Allison AC
    Ann N Y Acad Sci; 1993 Jun; 685():309-29. PubMed ID: 8363235
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
    Thervet E
    Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil for the transplanted kidney?
    Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.
    Smak Gregoor PJ; van Gelder T; Weimar W
    Neth J Med; 2000 Dec; 57(6):233-46. PubMed ID: 11099793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil.
    Lipsky JJ
    Lancet; 1996 Nov; 348(9038):1357-9. PubMed ID: 8918281
    [No Abstract]   [Full Text] [Related]  

  • 10. The design and development of an immunosuppressive drug, mycophenolate mofetil.
    Allison AC; Eugui EM
    Springer Semin Immunopathol; 1993; 14(4):353-80. PubMed ID: 8322167
    [No Abstract]   [Full Text] [Related]  

  • 11. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mycophenolate mofetil on hematocrit after renal transplantation.
    Chenhsu RY; Wu YM; Min DI; Zimmerman MB
    Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapse of atypical haemolytic uraemic syndrome after kidney transplantation: role of ATG and failure of mycophenolate mofetil as rescue therapy.
    Davin JC; Gruppen M; Bouts AH; Groothoff JW; van Amstel SP; Surachno J; ten Berge IJ; Weening JJ
    Nephrol Dial Transplant; 1999 Apr; 14(4):984-7. PubMed ID: 10328487
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients.
    Bestetti RB; Souza TR; Lima MF; Theodoropoulos TA; Cordeiro JA; Burdmann EA
    Transplantation; 2007 Aug; 84(3):441-2. PubMed ID: 17700175
    [No Abstract]   [Full Text] [Related]  

  • 16. [Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].
    Sánchez-Fructuoso AI
    Nefrologia; 2005; 25(3):234-42, 244. PubMed ID: 16053004
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil.
    McKane W; Kanganas C; Preston R; Cairns T; Hakim N; Palmer A; Taube D
    Transplant Proc; 2001; 33(1-2):1224-5. PubMed ID: 11267268
    [No Abstract]   [Full Text] [Related]  

  • 18. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
    Rerolle JP; Szelag JC; Le Meur Y
    Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil-associated enterocolitis.
    Liu TC; Amorosino MS; Cerda S; Farraye FA
    Gastrointest Endosc; 2006 Apr; 63(4):707-8, discussion 708. PubMed ID: 16564882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.